These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 27498834

  • 1. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H, Chen B, Duan B, Zheng J, Wu X.
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [Abstract] [Full Text] [Related]

  • 2. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W, Han W, Fan T, Wang X, Cheng Z, Wan B, Chen J.
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [Abstract] [Full Text] [Related]

  • 3. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
    Du G, Cao D, Meng L.
    Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM, Luo L, Ding XM, Dong DH, Li B, Ma XC, Sun LJ.
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [Abstract] [Full Text] [Related]

  • 5. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH, Gui DW.
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [Abstract] [Full Text] [Related]

  • 6. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J, Wang X, Wen G, Ren Y.
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [Abstract] [Full Text] [Related]

  • 7. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S, Ma X, Ai Q, Huang Q, Shi T, Zhu M, Wang B, Zhang X.
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [Abstract] [Full Text] [Related]

  • 8. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M, Cai L, Wang X, Yu Y, Jian W, Bao G, Gao Z, Guo J, Zhang J, Li C, Zhang C.
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [Abstract] [Full Text] [Related]

  • 9. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.
    Liu GL, Yang HJ, Liu B, Liu T.
    J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459
    [Abstract] [Full Text] [Related]

  • 10. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.
    Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE, Choudhury GG.
    PLoS One; 2012 Oct; 7(6):e37366. PubMed ID: 22685542
    [Abstract] [Full Text] [Related]

  • 11. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H, Sheng L, Tao J, Chen R, Li Y, Sun Z, Qian W.
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [Abstract] [Full Text] [Related]

  • 12. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z, Ma Z, Xu X.
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [Abstract] [Full Text] [Related]

  • 13. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X, Yu JJ.
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [Abstract] [Full Text] [Related]

  • 14. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X, Cui H, Lou Z, Huang S, Ren Y, Wang P, Weng G.
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
    Fan W, Huang J, Xiao H, Liang Z.
    Mol Med Rep; 2016 Jun; 13(6):4800-6. PubMed ID: 27082730
    [Abstract] [Full Text] [Related]

  • 16. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
    Wang H, Zhang P, Lin C, Yu Q, Wu J, Wang L, Cui Y, Wang K, Gao Z, Li H.
    PLoS One; 2015 Jun; 10(2):e114250. PubMed ID: 25714556
    [Abstract] [Full Text] [Related]

  • 17. Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
    Kalogirou C, Schäfer D, Krebs M, Kurz F, Schneider A, Riedmiller H, Kneitz B, Vergho D.
    Urol Int; 2016 Jun; 96(1):106-15. PubMed ID: 26496641
    [Abstract] [Full Text] [Related]

  • 18. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P, Kang B, Li Y, Hao W, Ma F.
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G, Chong T, Xiang X, Yang J, Li H.
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [Abstract] [Full Text] [Related]

  • 20. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR, Cai WP, Dai XJ, Guo AS, Chen HP, Lin GS, Lin RS.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.